StocksR › RCM

R1 RCM Inc. (RCM) — Earnings Call X-Ray

Our AI read all 30 of RCM's earnings calls (2017–2024) and answered the same battery of questions about each one. Every past call is free; the newest quarter unlocks with a free account.

Latest Call Grade
🔒
Q2 2024 · sign up to see
Previous Call Grade
C
Q1 2024
Expected Move
🔒
next 45 days · members
Calls Analyzed
30
2017–2024
Avg Candor
6.6/9
evasion 2.7/9
Guidance LoweredHigh CandorSkeptic ReassuredCritic AmmunitionVolume Step-UpBacklog GrowingResults Worse Than Direction

Call-by-call analysis

🔒 Q2 2024 earnings call 2024-08-07 NEWEST

Guidance: ■■■■■Demand: ■■■■■■ Margins: ■■■■Backlog: ■■■■ ■ analysts, ■■ questionsexpected move ±■■%
Candor /9
Specificity /9
Evasion /9
Stress /9

Management ■■■■■■ guidance against ■■■■■■■■ demand and ■■■■■■■ margins. The delivery was ■■■■■■■■ and ■■■■ in specifics, with ■■■ questions left hanging.

🔒 The Q2 2024 call grade is ready
The full 37-point AI read of RCM's newest earnings call — grade, expected move, and every question answered — is free with an account.
Sign up free to unlock

C Q1 2024 earnings call 2024-05-08 move ±10.8%

Management lowered guidance against steady demand. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: stableMargins: stableBacklog: growingCapex: flat 13 analysts · 13 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up aheadDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q4 2023 earnings call 2024-02-27 move ±14.8%

Management gave no formal guidance against steady demand and expanding margins. The delivery was rich in specifics.

Demand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: flat 9 analysts · 15 questions
⚑ Critic ammunition✓ Skeptic reassured⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts⚑ Reads rehearsed
Candor 6/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?

D Q3 2023 earnings call 2023-11-04 move ±18.1%

Management held guidance steady against accelerating demand and expanding margins. The delivery was rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: flat 11 analysts · 22 questions
⚑ Critic ammunition⚑ Question left hanging✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth⚑ Reads rehearsed
Candor 6/9
Specificity 7/9
Evasion 5/9
Confidence 7/9
Uncertainty 4/9
Promotion 6/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
YES Does the call read rehearsed rather than lived?
From the research question bank
1 more research questions answered NO

C Q2 2023 earnings call 2023-08-02 move ±11.8%

Management lowered guidance against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growing 10 analysts · 17 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growthDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 8/9
Uncertainty 4/9
Promotion 6/9
Stress 3/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

C+ Q1 2023 earnings call 2023-05-07 move ±7.9%

Management held guidance steady against steady demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: stableMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: flat 12 analysts · 20 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Early product, fast growth
Candor 7/9
Specificity 7/9
Evasion 2/9
Confidence 7/9
Uncertainty 4/9
Promotion 5/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
NO Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

B Q4 2022 earnings call 2023-02-16 move ±10.4%

Management held guidance steady against accelerating demand and expanding margins. The delivery was unusually candid, rich in specifics.

Guidance: maintainedDemand: acceleratingMargins: expandingBacklog: growingPricing: stableHeadcount: growingCapex: increasing 13 analysts · 24 questions
⚑ Critic ammunition✓ Skeptic reassured✓ Guidance underwritable✓ Resolves doubts✓ Volume step-up ahead✓ Early product, fast growth
Candor 7/9
Specificity 8/9
Evasion 2/9
Confidence 8/9
Uncertainty 3/9
Promotion 5/9
Stress 2/9
Complexity 6/9
All 20 questions our AI answered about this call
YES Would a skeptical short-seller find this call reassuring?
YES Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
YES Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
NO Does an obvious question remain unanswered?
YES Is a product early in its life but growing very fast?
YES Do they serve a small fraction of their addressable customers?
YES Is volume about to step up rather than grow gradually?
YES Are high fixed costs currently underutilised?
YES Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
YES Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

D Q3 2022 earnings call 2022-11-08 move ±28%

Management lowered guidance against mixed demand signals and contracting margins. The delivery was unusually candid, rich in specifics.

Guidance: loweredDemand: mixedMargins: contractingBacklog: growingPricing: under pressureHeadcount: growingCapex: increasing 7 analysts · 13 questions
⚑ Critic ammunition⚑ Question left hangingDirection beats results
Candor 7/9
Specificity 8/9
Evasion 3/9
Confidence 6/9
Uncertainty 5/9
Promotion 4/9
Stress 4/9
Complexity 6/9
All 20 questions our AI answered about this call
NO Would a skeptical short-seller find this call reassuring?
NO Would a careful investor underwrite management's guidance?
YES Is management's confidence proportionate to the evidence presented?
NO Does the call resolve more doubts than it creates?
YES Is there something a critic could fairly use against the company?
NO Is a claimed advantage dependent on scale they lack?
YES Does an obvious question remain unanswered?
NO Is a product early in its life but growing very fast?
NO Do they serve a small fraction of their addressable customers?
NO Is volume about to step up rather than grow gradually?
NO Are high fixed costs currently underutilised?
NO Is pricing recovering from a depressed level?
YES Do current results look bad while the direction looks better?
NO Are deferred revenue or customer prepayments growing?
NO Is consolidation happening among their peers?
NO Is a founder still running the company?
NO Does the final speaker sound like they are summarizing a finished story?
NO Is a fast-growing segment obscured by a declining one?
NO Does the CFO speak more than the CEO?
NO Does the call read rehearsed rather than lived?

Earlier calls

CallDateGradeGuidanceDemandMarginsCandorEvasion
Q2 2022 2022-08-03 C+ maintainedacceleratingstable 6/9 3/9
Q1 2022 2022-05-09 B maintainedacceleratingstable 7/9 2/9
Q4 2021 2022-02-17 C+ maintainedacceleratingexpanding 7/9 3/9
Q3 2021 2021-11-02 B raisedacceleratingexpanding 6/9 3/9
Q2 2021 2021-08-03 A raisedacceleratingexpanding 7/9 2/9
Q1 2021 2021-05-08 B maintainedacceleratingexpanding 7/9 2/9
Q4 2020 2021-02-18 A maintainedacceleratingexpanding 7/9 1/9
Q3 2020 2020-11-03 B+ raisedstablestable 6/9 2/9
Q2 2020 2020-08-04 A raisedacceleratingexpanding 7/9 3/9
Q1 2020 2020-05-06 C withdrawnslowingexpanding 8/9 2/9
Q4 2019 2020-02-20 B+ maintainedacceleratingexpanding 7/9 2/9
Q3 2019 2019-11-05 B maintainedacceleratingexpanding 6/9 3/9
Q2 2019 2019-08-06 C+ raisedacceleratingexpanding 6/9 4/9
Q1 2019 2019-05-10 B+ maintainedacceleratingexpanding 6/9 2/9
Q4 2018 2019-02-22 B maintainedacceleratingexpanding 7/9 2/9
Q3 2018 2018-11-10 B+ raisedacceleratingexpanding 6/9 2/9
Q2 2018 2018-08-09 C+ maintainedacceleratingexpanding 6/9 3/9
Q1 2018 2018-05-09 C+ maintainedacceleratingcontracting 6/9 3/9
Q4 2017 2018-03-09 B+ raisedacceleratingexpanding 7/9 3/9
Q3 2017 2017-10-31 C maintainedacceleratingexpanding 6/9 4/9
Q2 2017 2017-08-02 B+ raisedacceleratingcontracting 6/9 3/9
Q1 2017 2017-05-09 B+ raisedacceleratingexpanding 6/9 2/9

How to read this page

The grade is a transparent composite of call quality — candor, specificity, low evasion, low stress, whether the call resolves more doubts than it creates, and the guidance action — not a buy or sell signal. The expected move is a volatility estimate from the one signal that survived our out-of-sample tests: how a stock's own reaction and pre-call volatility predict the size (not direction) of its next move. Full detail, including everything that failed: methodology.

Companies with similar call quality

AAP · Advance Auto Parts, Inc.ABCAF · Athabasca Minerals, Inc.ABDC · Alcentra Capital'sABMD · Abiomed, Inc.ABNRY · ABN AMRO Bank N.V.ABOS · Acumen Pharmaceuticals,

RCL   All “R” companies    RCMT

Not investment advice. Artul.ai publishes AI-generated earnings-call quality grades and expected-volatility estimates — never buy or sell recommendations. We tested over 1,600 predictive hypotheses against 165,000 transcripts; the honest result, including what failed, is documented in our methodology.